Related Post
Belgian media said that Belgium was unable to obtain half of the doses scheduled to be obtained from Pfizer to treat symptoms of the Corona virus, at the specified time at the beginning of next January.
For his part, Dirk Rammakers, head of the vaccination team in Belgium, said that even if Pfizer had revised its production schedule by the end of February, that would not be a problem for Belgium.
Pfizer faces delays in its production of the Coronavirus vaccine at the international level. As a result, Belgium will receive at the beginning of next January 300,000 doses of the vaccine instead of the prescribed 600,000 doses, which means that in the first phase, only 150,000 people can be vaccinated, Instead of the planned 300,000, because two doses per person are necessary.
According to Dirk Rammakers, nothing threatens the first stage A1 Which provides for the vaccination of residents and workers in homes for the elderly and care institutions, adding that it can still start as planned on January 5..
“We expect Pfizer to catch up by the end of February, and if it succeeds, then there is no problem, and we have enough to vaccinate all residents and staff in nursing and care homes as of January, and the results of Phase 1 will be,” Ramacers said.A Limited.
For his part, an epidemiologist from the University of Antwerp, Pierre Van Dam, stressed that the situation does not concern Belgium only, but also all the member states of the European Union, adding that he believes, like Dirk Rammakers, that “this certainly will not expose the vaccination campaign to any risks.”
